Nxera Pharma Co., Ltd.
SOLTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $32 | $49 | $67 | $60 |
| Short-Term Investments | $4 | $0 | $0 | $0 |
| Receivables | $7 | $5 | $2 | $2 |
| Inventory | $9 | $3 | $0 | -$0 |
| Other Curr. Assets | $6 | $8 | $1 | $1 |
| Total Curr. Assets | $58 | $65 | $70 | $63 |
| Property Plant & Equip (Net) | $7 | $8 | $4 | $4 |
| Goodwill | $26 | $25 | $15 | $15 |
| Intangibles | $52 | $52 | $9 | $9 |
| Long-Term Investments | $1 | $3 | $2 | $6 |
| Tax Assets | $4 | $4 | $1 | $0 |
| Other NC Assets | $4 | $0 | -$1 | $0 |
| Total NC Assets | $94 | $92 | $29 | $34 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $151 | $157 | $99 | $97 |
| Liabilities | – | – | – | – |
| Payables | $4 | $4 | $2 | $1 |
| Short-Term Debt | $7 | $7 | -$0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $1 | $0 | $0 |
| Other Curr. Liab. | $5 | $4 | $2 | $5 |
| Total Curr. Liab. | $16 | $17 | $4 | $7 |
| LT Debt | $61 | $67 | $30 | $29 |
| Deferred Rev, NC | $0 | $0 | $5 | $0 |
| Deferred Tax Liab, NC | $2 | $1 | $3 | $3 |
| Other NC Liab. | $4 | $5 | $0 | $0 |
| Total NC Liab. | $67 | $73 | $37 | $32 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $4 | $5 | $2 | $2 |
| Total Liabilities | $83 | $90 | $41 | $40 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $47 | $47 | $41 | $41 |
| Retained Earnings | -$21 | -$16 | -$9 | -$10 |
| AOCI | $7 | $2 | -$4 | -$3 |
| Other Equity | $35 | $34 | $30 | $29 |
| Total Equity | $69 | $67 | $58 | $57 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $151 | $157 | $99 | $97 |
| Net Debt | $36 | $25 | -$37 | -$31 |